Plain-English translation of NCT07051187 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage trial testing , an experimental vaccine designed to help treat chronic hepatitis B by training your immune system to recognize and eliminate the hepatitis B virus. The vaccine is given by injection and has shown promising results in laboratory studies, potentially helping to clear the virus and reduce levels of hepatitis B surface antigen in the blood.
Current hepatitis B medications can control the virus but rarely cure it completely. This medication represents a new approach—a therapeutic vaccine—that aims to activate your body's natural immune defenses to actually eliminate the virus rather than just suppress it.
You likely qualify if…
You likely don't qualify if…
You would receive a total of 9 injections of the study vaccine given into your muscle over the course of the trial. You would need to visit the clinic for injections and safety monitoring, and researchers would take blood samples to check how your body is responding to the vaccine and how your hepatitis B is progressing. The trial is designed to evaluate both how well the treatment works and how safe it is.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
China